free hit counters
French Biotech Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

MAR Weekly Report_VIRBAC SA_11 to 15 September 2023

Return to news


Statement of transactions in own shares from September 11, 2023 to September 15, 2023BNP PARIBAS EXANE
            
Aggregated presentation by day and by market          
            
Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *Market (MIC Code)   
VIRBAC SA 11/09/2023FR0000031577141264.5035AQEU   
VIRBAC SA 11/09/2023FR0000031577299264.0502CEUX   
VIRBAC SA 11/09/2023FR000003157723266.4348TQEX   
VIRBAC SA 11/09/2023FR00000315771,037264.0921XPAR   
VIRBAC SA 12/09/2023FR0000031577148264.9797AQEU   
VIRBAC SA 12/09/2023FR0000031577314265.0064CEUX   
VIRBAC SA 12/09/2023FR000003157724264.7292TQEX   
VIRBAC SA 12/09/2023FR00000315771,014265.0592XPAR   
VIRBAC SA 13/09/2023FR0000031577151262.8245AQEU   
VIRBAC SA 13/09/2023FR0000031577322262.7360CEUX   
VIRBAC SA 13/09/2023FR000003157725262.2400TQEX   
VIRBAC SA 13/09/2023FR0000031577914262.4305XPAR   
VIRBAC SA 14/09/2023FR0000031577151263.0099AQEU   
VIRBAC SA 14/09/2023FR0000031577325262.8692CEUX   
VIRBAC SA 14/09/2023FR000003157725263.1400TQEX   
VIRBAC SA 14/09/2023FR0000031577448262.1953XPAR   
VIRBAC SA 15/09/2023FR0000031577154263.4058AQEU   
VIRBAC SA 15/09/2023FR0000031577327263.6606CEUX   
VIRBAC SA 15/09/2023FR000003157723264.4130TQEX   
VIRBAC SA 15/09/2023FR0000031577991263.3925XPAR   
          
* Four-digit rounding after the decimal TOTAL6,856263.6478    
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
Details per transaction         
            
Name of issuerIdentification code issuer (Legal Entity Identifier)Name of Investment Services ProviderIdentification code of Investment Services ProviderDay/time of transaction (CET)Identification code of financial instrumentPrice per transactionCurrencyAcquired volumeMarket (MIC Code)Reference number of transactionPurpose of buy back
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:00:20FR0000031577265.50EUR1CEUX00352552766EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:00:20FR0000031577265.50EUR13CEUX00352552767EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:00:20FR0000031577265.50EUR1CEUX00352552768EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:05:02FR0000031577266.00EUR13XPAR00352553231EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:10:02FR0000031577265.00EUR5XPAR00352553513EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:12:12FR0000031577266.00EUR10XPAR00352553674EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:12:12FR0000031577266.00EUR5XPAR00352553675EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:34:25FR0000031577266.00EUR16CEUX00352555277EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 09:34:25FR0000031577266.00EUR35XPAR00352555278EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR37AQEU00352558505EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR6CEUX00352558504EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR14CEUX00352558506EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR7CEUX00352558507EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR3CEUX00352558508EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR7CEUX00352558509EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR8CEUX00352558512EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577266.50EUR14TQEX00352558513EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577266.50EUR8TQEX00352558514EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR43XPAR00352558510EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:17FR0000031577267.00EUR12XPAR00352558511EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:22FR0000031577267.00EUR7XPAR00352558529EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:22FR0000031577267.00EUR10XPAR00352558530EXPA1
VIRBAC SA Exane SA969500UP76J52A9OXU2711/09/2023 10:14:22FR0000031577267.00EUR13XPAR00352558531EXPA1
VIRBAC SA  GlobeNewswire
By: GlobeNewswire - 18 Sep 2023
Return to news

Partners

Upcoming Life Sciences Events

  • September 2023
    • Diegem: Pharma-Biotech Product & Company Valuation with Dr. P Frei
    • Barcelona: BioSpain 2023
  • October 2023
    • New York City: BioFuture

Latest company news

Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review
26 Sep 2023 (GlobeNewswire)

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
25 Sep 2023 (GlobeNewswire)

Novo Nordisk A/S - share repurchase programme
25 Sep 2023 (GlobeNewswire)

Biotechgate database

About Biotechgate
The French Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com